Explore the words cloud of the EUNCL project. It provides you a very rough idea of what is the project "EUNCL" about.
The following table provides information about the project.
Coordinator |
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
Organization address contact info |
Coordinator Country | France [FR] |
Project website | http://www.eu-ncl.eu |
Total cost | 5˙627˙303 € |
EC max contribution | 4˙995˙181 € (89%) |
Programme |
1. H2020-EU.1.4.1.2. (Integrating and opening existing national and regional research infrastructures of European interest) |
Code Call | H2020-INFRAIA-2014-2015 |
Funding Scheme | RIA |
Starting year | 2015 |
Duration (year-month-day) | from 2015-05-01 to 2019-12-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES | FR (PARIS 15) | coordinator | 944˙426.00 |
2 | GESELLSCHAFT FUR BIOANALYTIK MUNSTER EV | DE (MUNSTER) | participant | 866˙206.00 |
3 | JRC -JOINT RESEARCH CENTRE- EUROPEAN COMMISSION | BE (BRUSSELS) | participant | 827˙472.00 |
4 | THE UNIVERSITY OF LIVERPOOL | UK (LIVERPOOL) | participant | 650˙716.00 |
5 | STIFTELSEN SINTEF | NO (TRONDHEIM) | participant | 613˙910.00 |
6 | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN | IE (DUBLIN) | participant | 442˙433.00 |
7 | LEIDOS BIOMEDICAL RESEARCH INC | US (FREDERICK MD) | participant | 273˙700.00 |
8 | SINTEF AS | NO (TRONDHEIM) | participant | 273˙436.00 |
9 | EUROPEAN RESEARCH SERVICES GMBH | DE (MUENSTER) | participant | 102˙880.00 |
10 | EIDGENOSSISCHE MATERIALPRUFUNGS- UND FORSCHUNGSANSTALT | CH (DUBENDORF) | participant | 0.00 |
In order to accelerate the development of the nanomedicine business in Europe, EU-NCL interconnects 8 European and 1 American key reference facilities with a proven expertise in physical, chemical, in vitro and in vivo biological characterisation of nanoparticles for medical applications. The objective is to reach a level of international excellence in nanomedicine characterization for all medical indication, and make it accessible to all organisations developing candidate nanomedicines prior to their submission to the regulatory agencies in order to get the approval for clinical trials and later the marketing authorization. EU-NCL is partnered with the sole international reference facility namely the Nanotechnology Characterisation Lab of the USA to get a faster international harmonization of analytical protocols. EU-NCL is closely connected to national medicine agencies and to the European Medicine Agency in order to permanently adapt its analytical services to the need and requests of the regulators. EU-NCL is designed, organized and operated according to the highest EU regulatory and quality standards in order to provide a full analytical cascade of 42 assays. Within EU-NCL, 6 analytical facilities will offer a Trans National Access to their existing analytical services but they will also develop new or improved analytical assays under the Joint Research Activities in order to keep EU-NCL at the cutting edge of the nanomedicine characterisation. A complementary set of networking activities will make EU-NCL able to deliver to the European academic or industrial scientists the best analytical services they dramatically require for accelerating the industrial development of their candidate nanomedicines. An exploitation and business plan will be proposed at the end of the project in order to submit a sustainable development plan beyond the initial period of 4 years.
1st report on modeling of analytical decision process | Documents, reports | 2019-05-28 15:42:58 |
Activities to promote innovation through partnership with industry – 2nd report | Documents, reports | 2019-05-28 15:42:47 |
Sample receiving laboratory installed | Demonstrators, pilots, prototypes | 2019-05-28 15:42:27 |
EU-NCL annual workshop –year 3 | Websites, patent fillings, videos etc. | 2019-05-28 15:42:56 |
1st Collection of approved measurement SOPs | Demonstrators, pilots, prototypes | 2019-05-28 15:42:31 |
2nd Completed survey with regulatory bodies | Documents, reports | 2019-05-28 15:42:59 |
1st report on reviews of QMS of EU-NCL | Documents, reports | 2019-05-28 15:42:29 |
1st List of candidate technologies | Documents, reports | 2019-05-28 15:42:51 |
2nd Data management plan | Documents, reports | 2019-05-28 15:42:35 |
Publication of 3rd TNA open call | Websites, patent fillings, videos etc. | 2019-05-28 15:42:42 |
1st Prioritized list of candidate technologies | Documents, reports | 2019-05-28 15:42:42 |
TNA “guide for applicant†& evaluation form | Other | 2019-05-28 15:42:30 |
CMS developed | Other | 2019-05-28 15:42:29 |
1st report on the testing and optimization of novel technologies | Documents, reports | 2019-05-28 15:42:57 |
Publication of 2nd TNA open call | Websites, patent fillings, videos etc. | 2019-05-28 15:42:48 |
CMS implemented | Documents, reports | 2019-05-28 15:42:35 |
Liaison activities with external stakeholders – 1st report | Documents, reports | 2019-05-28 15:42:33 |
Activities to promote innovation through partnership with industry– 1st report | Documents, reports | 2019-05-28 15:42:46 |
EU-NCL website | Websites, patent fillings, videos etc. | 2019-05-28 15:42:33 |
Publication of 1st TNA open call | Websites, patent fillings, videos etc. | 2019-05-28 15:42:33 |
EU-NCL annual workshop –year 2 | Websites, patent fillings, videos etc. | 2019-05-28 15:42:38 |
Appointment of the peer review evaluation board | Other | 2019-05-28 15:42:41 |
1st completed survey with regulatory bodies | Documents, reports | 2019-05-28 15:42:50 |
2nd Collection of approved measurement SOPs | Demonstrators, pilots, prototypes | 2019-05-28 15:42:24 |
2nd List of candidate technologies | Documents, reports | 2019-05-28 15:42:58 |
2nd Prioritized list of candidate technologies | Documents, reports | 2019-05-28 15:42:49 |
Publication of “State-of-the-art†manuscript – version 1 | Websites, patent fillings, videos etc. | 2019-05-28 15:43:00 |
3rd Collection of approved measurement SOPs | Demonstrators, pilots, prototypes | 2019-05-28 15:42:32 |
1st Data management plan | Documents, reports | 2019-05-28 15:42:31 |
2nd report on reviews of QMS of EU-NCL | Documents, reports | 2019-05-28 15:42:55 |
Take a look to the deliverables list in detail: detailed list of EUNCL deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2019 |
F. Caputo, J. Clogston, L. Calzolai, M. Rösslein, A. Prina-Mello Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity published pages: 31-43, ISSN: 0168-3659, DOI: 10.1016/j.jconrel.2019.02.030 |
Journal of Controlled Release 299 | 2019-09-02 |
2017 |
Dora Mehn, Patrizia Iavicoli, Noelia Cabaleiro, Sven Even Borgos, Fanny Caputo, Otmar Geiss, Luigi Calzolai, François Rossi, Douglas Gilliland Analytical ultracentrifugation for analysis of doxorubicin loaded liposomes published pages: 320-326, ISSN: 0378-5173, DOI: 10.1016/j.ijpharm.2017.03.046 |
International Journal of Pharmaceutics 523/1 | 2019-06-12 |
2018 |
Fanny Caputo, Amandine Arnould, Maria Bacia, Wai Li Ling, Emilie Rustique, Isabelle Texier, Adriele Prina Mello, Anne-Claude Couffin Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles published pages: 756-767, ISSN: 1543-8384, DOI: 10.1021/acs.molpharmaceut.8b01033 |
Molecular Pharmaceutics 16/2 | 2019-04-19 |
2017 |
D. Mehn, F. Caputo, M. Rösslein, L. Calzolai, F. Saint-Antonin, T. Courant, P. Wick, D. Gilliland Larger or more? Nanoparticle characterisation methods for recognition of dimers published pages: 27747-27754, ISSN: 2046-2069, DOI: 10.1039/c7ra02432k |
RSC Advances 7/44 | 2019-04-19 |
2018 |
Sabrina Gioria, Fanny Caputo, Patricia Urbán, Ciarán Manus Maguire, Susanne Bremer-Hoffmann, Adriele Prina-Mello, Luigi Calzolai, Dora Mehn Are existing standard methods suitable for the evaluation of nanomedicines: some case studies published pages: 539-554, ISSN: 1743-5889, DOI: 10.2217/nnm-2017-0338 |
Nanomedicine 13/5 | 2019-04-19 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EUNCL" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "EUNCL" are provided by the European Opendata Portal: CORDIS opendata.